|
Gulf
Pharmaceutical Industries (Julphar) is a public
shareholding company, based in the Emirate of Ras Al
Khaimah in UAE and listed on the Abu Dhabi Stock
Exchange. The company manufactures pharmaceutical
products that address a range of therapeutic
segments. It was established in 1980 under the
guidance of the late Sheikh Saqr Bin Mohammed Al
Qasimi, the former ruler of Ras Al Khaimah. His
Highness etched his legacy when he envisioned a
pharmaceutical company that will make the UAE
self-sufficient in all of its therapeutic needs,
providing quality medicines at accessible
|
|
|
prices.
True to his vision, Julphar has since its inception,
grown into a world class, state-of-the-art
pharmaceutical manufacturing company in the Middle
East and North Africa. Julphar has the distinction
of being not only the first pharmaceutical
manufacturing company in the Gulf, but also the only
pharmaceutical producer of its scale and size in the
UAE. It is also one of the largest in the entire
Middle East region. The total turnover for Julphar
in 2010 reached AED 920.2 million. |
|
|
Starting
with its first plant in 1984, Julphar has rapidly
evolved into a true multinational organization with
a widespread marketing network. With 11 production
facilities located in UAE and with global reach for
its products, Julphar represents the UAE’s
entrepreneurial capabilities. Julphar recently won
the Arab Achievement Award for 2011. The award was
organized by Global Business in collaboration with
the Dubai Knowledge Village and was hosted during
the 2nd Arab Conference for Investment in Abu Dhabi.
The award highlights the importance of Julphar in
the Middle East in providing quality pharmaceuticals
through various important healthcare projects.
|
Top